Serological Changes of Monoclonal Antibody CAMA3C8 against Human Breast Cancer Cell Line

Muninathan, N. and Ponnazhagan, K. and Meghalatha, T. S. (2021) Serological Changes of Monoclonal Antibody CAMA3C8 against Human Breast Cancer Cell Line. Journal of Pharmaceutical Research International, 33 (59A). pp. 406-412. ISSN 2456-9119

[thumbnail of 7163-Article Text-9604-1-10-20221006.pdf]

Text
7163-Article Text-9604-1-10-20221006.pdf - Published Version
Download (307kB)

Official URL: https://doi.org/10.9734/jpri/2021/v33i59A34284

Abstract

Background: Tumor associated antigen are glycoproteins and glycolipids expressed on the surface or in the cytoplasm of tumor cells. The antigenic components are shed from the tumor cells into the tissue culture medium or blood or other human body fluids like human milk.

Objective: In the present study, investigate the serological assay of the antigen recognized by CAMA3C8 in patients with carcinoma of the breast.

Methods: The study is desgriptive cross section study.The study was divited into four groups based on the expression of tumor associated antigen.

Results: In breast cancer CAMA3C8 levels were significantly increased in stage 4 when compared with stage 1 breast cancer cell line.

Conclusion: In the present study, we conclude that significantly recognized CAMA3C8 defined antigens in breast cancer.

Item Type:	Article
Subjects:	Library Keep > Medical Science
Depositing User:	Unnamed user with email support@librarykeep.com
Date Deposited:	20 Feb 2023 10:13
Last Modified:	10 Jan 2024 04:28
URI:	http://archive.jibiology.com/id/eprint/74

Actions (login required)

: View Item